000 01393 a2200385 4500
005 20250513052154.0
264 0 _c19941103
008 199411s 0 0 eng d
022 _a0028-4793
024 7 _a10.1056/NEJM199411033311804
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDonadio, J V
245 0 0 _aA controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group.
_h[electronic resource]
260 _bThe New England journal of medicine
_cNov 1994
300 _a1194-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aCreatinine
_xmetabolism
650 0 4 _aFatty Acids, Omega-3
_xadverse effects
650 0 4 _aFemale
650 0 4 _aGlomerulonephritis, IGA
_xcomplications
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aKidney Failure, Chronic
_xetiology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPatient Compliance
650 0 4 _aTreatment Outcome
700 1 _aBergstralh, E J
700 1 _aOfford, K P
700 1 _aSpencer, D C
700 1 _aHolley, K E
773 0 _tThe New England journal of medicine
_gvol. 331
_gno. 18
_gp. 1194-9
856 4 0 _uhttps://doi.org/10.1056/NEJM199411033311804
_zAvailable from publisher's website
999 _c7934988
_d7934988